Good lord ffrol, you're like pumpers. PLacing sky high expectations for this NON OPTIMIZED drug that was given for 12 days, then not given for 12 days (during which time any gains may have been lost entirely and the disease progressed), and then added back for 12 days (which may have been like starting from scratch with the drug). They were only a non optimized drug for 24 non consequetive days and it is like you're expecting them to have made major leaps and bounds in that short timespan. Be realistic man. It is not fair to place those kind of expectations upon an early, 12 day trial. You forget there was a washout. Geesh. No drug would make it make to market if it had to meet your rigid standards right out the gate.
Market Data 
Markets 
AI
